Admissions to a medical intensive care unit related to adverse drug reactions

American Journal of Health-System Pharmacy

Volumn 64, Issue 17, 2007, Pages 1840-1843

  Rivkin, Anastasia ^a,b  

^a LONG ISLAND UNIVERSITY   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Antiinflammatory agents; Aspirin; Clopidogrel; Death; Drug interactions; Hemorrhage; Hospitals; Platelet aggregation inhibitors; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMOXICILLIN PLUS CLAVULANIC ACID; BENZATHINE PENICILLIN; CELECOXIB; CLOMIPRAMINE; CLOPIDOGREL; COTRIMOXAZOLE; CYCLOOXYGENASE 2 INHIBITOR; DIGOXIN; ENOXAPARIN; FOSCARNET; FUROSEMIDE; GANCICLOVIR; HALOPERIDOL; IBUPROFEN; INSULIN; INSULIN GLARGINE; IRBESARTAN; LISINOPRIL; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; PROCAINE; RISPERIDONE; SPIRONOLACTONE; TRANYLCYPROMINE; WARFARIN; ANTITHROMBOCYTIC AGENT; DRUG; DRUG DERIVATIVE; TICLOPIDINE;

ACUTE KIDNEY FAILURE; ANAPHYLAXIS; ARTICLE; BLEEDING; BRADYCARDIA; DISEASE SEVERITY; DRUG FATALITY; EPISTAXIS; FACE EDEMA; GASTROINTESTINAL HEMORRHAGE; HALLUCINATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER HEMATOMA; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; SEIZURE; SEROTONIN SYNDROME; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; STATISTICS; TEACHING HOSPITAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; HEMORRHAGE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; MALE; PHARMACEUTICAL PREPARATIONS; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 34848859315     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060641     Document Type: Article

References (17)

1. Roughead EE, Gilbert AL, Primrose JG et al. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust. 1998; 168:405-8.
2. Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004; 329:15-9.
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279:1200-5.
4. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995; 155:1949-56.
5. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health-Syst Pharm. 1997; 54:554-8.
6. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001; 41:192-9.
7. Smith KM, Jeske CS, Young B et al. Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients. Neurosurgery. 2006; 58:426-33.
8. Dubaybo BA, Dingell JD. Adverse drug reactions in the ICU: lessons learned. Chest. 2005; 128:1100-1.
9. Vargas E, Terleira A, Hernando F et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med. 2003; 31:694-8. [Erratum, Crit Care Med. 2003; 31:2816.]
10. International drug monitoring. The role of the hospital. World Health Organ Tech Rep Ser. 1969; 425:5-24.
11. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
12. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992; 27:538. Letter.
13. Al-Tajir GK, Kelly WN. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother. 2005; 39:1169-74.
14. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy. 1996; 16:701-7.
15. Samoy LJ, Zed PJ, Wilbur K et al. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy. 2006; 26:1578-86.
16. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med. 1994; 154:42-6.
17. Frank C, Godwin M, Verma S et al. What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use? Can Fam Physician. 2001; 47:1198-204.